Cargando…
Down-regulation of SerpinB2 is associated with gefitinib resistance in non-small cell lung cancer and enhances invadopodia-like structure protrusions
The failure of targeted therapy due to the resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib, is considered a major problem in the treatment of non-small cell lung cancer (NSCLC) patients. SerpinB2, a component of the urokinase plasminogen activ...
Autores principales: | Bae, Song Yi, Park, Hyen Joo, Hong, Ji-Young, Lee, Hye-Jung, Lee, Sang Kook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997607/ https://www.ncbi.nlm.nih.gov/pubmed/27558531 http://dx.doi.org/10.1038/srep32258 |
Ejemplares similares
-
IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease
por: Biasiolo, Alessandra, et al.
Publicado: (2012) -
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
por: Biasiolo, Alessandra, et al.
Publicado: (2023) -
Induction of SerpinB2 and Th1/Th2 Modulation by SerpinB2 during Lentiviral Infections In Vivo
por: Major, Lee D., et al.
Publicado: (2013) -
Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer
por: Bae, Song Yi, et al.
Publicado: (2015) -
Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression
por: Piao, Yin Ji, et al.
Publicado: (2022)